You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
可孚醫療(301087.SZ):核心技術人員調整 將設立醫療電子與康復醫學研究院、生物傳感與創新材料研究院
格隆匯 11-07 17:56

格隆匯11月7日丨可孚醫療(301087.SZ)公佈,公司核心技術人員之一王克鎮因個人原因辭去相關職務,並於近日辦理完畢離職手續。離職後,王克鎮將不在公司擔任任何職務。

王克鎮於2018 6 月加入公司,擔任公司研發一部總監,負責構建和搭建研發體系,規劃電子檢測類等新產品的研發計劃;負責產品研製過程中關鍵技術的突破工作。主導參與完成電子血壓計、霧化器等項目的研發工作。

公司已安排相關人員接替其所負責的工作,並已實現平穩交接、過渡。王克鎮的離職不會對公司生產和經營帶來不利影響,不會影響公司持有的核心技術。根據王克鎮與公司簽署的《保密協議》,王克鎮在離職後仍對其接觸、知悉的公司保密信息負有保密義務。

進一步提升創新能力和技術水平,適應公司戰略佈局,經公司第一屆董事會第十七次會議審議,將設立醫療電子與康復醫學研究院、生物傳感與創新材料研究院。根據公司實際情況,結合任職履歷、未來對公司研發項目和業務發展的領導及參與情況等因素,經公司總裁辦公會議審議通過新增認定李勇、付亞成、張紹達為公司核心技術人員

公吿顯示,李勇,19811月出生,中國國籍,無境外永久居留權,畢業於上海交通大學電子工程系,碩士研究生學歷。曾任中興通訊股份有限公司3G軟件工程師諾基亞北京公司3G/4G系統測試部骨幹、全球技術支持部經理Saudi Mobily Company 資深顧問諾基亞北京公司大區產品總監任公司智能研究院院長,任公司醫療電子與康復醫學研究院院長兼任呼吸支持研究所所長。

付亞成,19851月出生,中國國籍,無境外永久居留權,畢業於湖南農業大學碩士研究生學歷,現就讀於中南大學湘雅醫院生物醫藥專業,博士在讀任聖湘生物股份有限公司研發主管Qiagen(凱傑)公司研發項目經理公司研發三部副總監,任公司生物傳感與創新材料研究院副院長。

張紹達,19863月出生,中國國籍,無境外永久居留權,韓國慶北國立大學微電子專業、廈門大學薩本棟微電子學與固體電子專業博士,深圳孔雀人才,研發方向為MEMS感器和微流控。現任公司深圳研發中心負責人,主要研究連續血糖監測系統、敏感體合成工藝、精密點膠工藝,微納加工等。

目前,公司研發團隊結構完整,後備人員充足,現有研發團隊及核心技術人員能夠支持公司核心技術及創新產品的持續開發。後續公司將進一步加大專業技術人員的引進和培養,優化研發人員考核獎勵機制,不斷提升公司的技術創新能

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account